Gene Therapy GNT0004 Demonstrates Early Efficacy, Safety in Duchenne Muscular Dystrophy

Retrieved on: 2024-06-12 22:08:07

Tags for this article:

Click the tags to see associated articles and topics

Gene Therapy GNT0004 Demonstrates Early Efficacy, Safety in Duchenne Muscular Dystrophy. View article details on hiswai:

Excerpt

Data from an early-stage trial showed that treatment with GNT0004 (Genethon), an investigational adeno-associated virus (AAV8) vector-based gene ...

Article found on: www.neurologylive.com